NDC 71753-8099

Cellergy

Calcarea Fluorica, Calcarea Phosphorica, Calcarea Sulphurica, Ferrum Phosphoricum, Kali Muriaticum, Kali Phosphoricum, Kali Sulphuricum, Magnesia Phosphorica, Natrum Muriaticum, Natrum Phosphoricum, Natrum Sulphuricum, Silicea.

Cellergy is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Ratis, Llc. The primary component is Calcium Fluoride; Calcium Sulfate Anhydrous; Dibasic Potassium Phosphate; Ferrosoferric Phosphate; Magnesium Phosphate, Dibasic Trihydrate; Potassium Chloride; Potassium Sulfate; Silicon Dioxide; Sodium Chloride; Sodium Phosphate, Dibasic, Heptahydrate; Sodium Sulfate; Tribasic Calcium Phosphate.

Product ID71753-8099_5f471122-6961-4be6-bfce-20cae3e45475
NDC71753-8099
Product TypeHuman Otc Drug
Proprietary NameCellergy
Generic NameCalcarea Fluorica, Calcarea Phosphorica, Calcarea Sulphurica, Ferrum Phosphoricum, Kali Muriaticum, Kali Phosphoricum, Kali Sulphuricum, Magnesia Phosphorica, Natrum Muriaticum, Natrum Phosphoricum, Natrum Sulphuricum, Silicea.
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date2019-10-08
Marketing End Date2025-12-01
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRatis, LLC
Substance NameCALCIUM FLUORIDE; CALCIUM SULFATE ANHYDROUS; DIBASIC POTASSIUM PHOSPHATE; FERROSOFERRIC PHOSPHATE; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; POTASSIUM CHLORIDE; POTASSIUM SULFATE; SILICON DIOXIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM SULFATE; TRIBASIC CALCIUM PHOSPHATE
Active Ingredient Strength12 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
Pharm ClassesBlood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
NDC Exclude FlagN

Packaging

NDC 71753-8099-1

30 mL in 1 BOTTLE, SPRAY (71753-8099-1)
Marketing Start Date2019-10-08
Marketing End Date2025-12-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71753-8099-1 [71753809901]

Cellergy LIQUID
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2019-10-08

Drug Details

Active Ingredients

IngredientStrength
CALCIUM FLUORIDE12 [hp_X]/mL

Trademark Results [Cellergy]

Mark Image

Registration | Serial
Company
Trademark
Application Date
CELLERGY
CELLERGY
98303056 not registered Live/Pending
Cellergy Therapeutics, Inc.
2023-12-07
CELLERGY
CELLERGY
78219251 not registered Dead/Abandoned
Superior Associates, Inc.
2003-02-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.